Cat. No. | Species | Product Description | Structure | Purity | Feature |
---|---|---|---|---|---|
IL1-H5114 | Human | Human IL-21 Protein (E. coli), premium grade | ![]() |
![]() ![]() ![]() ![]() |
![]() ![]() |
GMP-L21H25 | Human | GMP Human IL-21 Protein | ![]() |
![]() ![]() |
|
IL1-M52H3 | Mouse | Mouse IL-21 Protein, His Tag | ![]() |
![]() ![]() |
![]() ![]() |
CRS-A010 | Human | resDetect™ Human Interleukin-21 (IL-21) ELISA Kit (Residue Testing) | |||
IL1-C52H9 | Cynomolgus | Cynomolgus IL-21 Protein, His Tag | ![]() |
![]() ![]() |
![]() ![]() |
IL1-H5213 | Human | Human IL-21 Protein, premium grade | ![]() |
![]() ![]() ![]() ![]() |
|
IL1-H5253 | Human | Human IL-21 Protein, Fc Tag | ![]() |
![]() ![]() |
![]() ![]() |
IL1-H82F7 | Human | Biotinylated Human IL-21 Protein, Fc,Avitag™, premium grade | ![]() |
![]() ![]() |
![]() ![]() ![]() ![]() |
Human IL-21 Protein (E. coli), premium grade (Cat. No. IL1-H5114) stimulates secretion of IFN-γ by NK-92 human natural killer lymphoma cells stimulated with GMP Human IL-15 Protein (Cat. No. GMP-L15H13). The specific activity of Human IL-21 Protein (E. coli), premium grade is > 1.00 × 10^5 U/mg (QC tested).
GMP Human IL-21 Protein (Cat. No. GMP-L21H25) stimulates secretion of IFN-γ by NK-92 human natural killer lymphoma cells stimulated with 10 ng/mL GMP Human IL-15 Protein (Cat. No. GMP-L15H13). The specific activity of GMP Human IL-21 Protein (Cat. No. GMP-L21H25) is > 1.00×10^5 U/mg (QC tested).
Biotinylated Human IL-21, Fc,Avitag, premium grade (Cat. No. IL1-H82F7) immobilized on CM5 Chip can bind Human IL-21 R, Fc Tag (Cat. No. ILR-H5257) with an affinity constant of 0.165 nM as determined in a SPR assay (Biacore 8K) (Routinely tested).
Name | Research Code | Research Phase | Company | Indications | Clinical Trials |
---|---|---|---|---|---|
Avizakimab | BOS-161721 | Phase 2 Clinical | Medimmune, Boston Pharmaceuticals Inc | Lupus Erythematosus, Systemic | Details |
hV-01 | hV-01 | Phase 2 Clinical | Hangzhou Converd Co Ltd | Sarcoma 180; Solid tumours; Uterine Cervical Neoplasms | Details |
IL-21 mab (Lilly) | Phase 1 Clinical | Eli Lilly And Company | Immune System Diseases | Details |
This web search service is supported by Google Inc.